- Home
- YMAB vs SEVN Comparison
YMAB vs SEVN Comparison
Compare YMAB & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- SEVN
- Stock Information
- Founded
- YMAB 2015
- SEVN 1986
- Country
- YMAB United States
- SEVN United States
- Employees
- YMAB N/A
- SEVN N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- SEVN Real Estate Investment Trusts
- Sector
- YMAB Health Care
- SEVN Real Estate
- Exchange
- YMAB Nasdaq
- SEVN Nasdaq
- Market Cap
- YMAB 192.4M
- SEVN 173.7M
- IPO Year
- YMAB 2018
- SEVN N/A
- Fundamental
- Price
- YMAB $4.60
- SEVN $11.79
- Analyst Decision
- YMAB Buy
- SEVN Strong Buy
- Analyst Count
- YMAB 11
- SEVN 4
- Target Price
- YMAB $17.55
- SEVN $14.50
- AVG Volume (30 Days)
- YMAB 226.0K
- SEVN 34.8K
- Earning Date
- YMAB 05-13-2025
- SEVN 07-28-2025
- Dividend Yield
- YMAB N/A
- SEVN 11.77%
- EPS Growth
- YMAB N/A
- SEVN N/A
- EPS
- YMAB N/A
- SEVN 1.15
- Revenue
- YMAB $88,658,000.00
- SEVN $30,074,000.00
- Revenue This Year
- YMAB N/A
- SEVN $14.81
- Revenue Next Year
- YMAB $16.03
- SEVN $2.73
- P/E Ratio
- YMAB N/A
- SEVN $10.26
- Revenue Growth
- YMAB 4.92
- SEVN N/A
- 52 Week Low
- YMAB $3.55
- SEVN $10.18
- 52 Week High
- YMAB $16.11
- SEVN $14.66
- Technical
- Relative Strength Index (RSI)
- YMAB 56.43
- SEVN 50.01
- Support Level
- YMAB $3.99
- SEVN $11.58
- Resistance Level
- YMAB $5.00
- SEVN $11.99
- Average True Range (ATR)
- YMAB 0.35
- SEVN 0.36
- MACD
- YMAB 0.10
- SEVN 0.02
- Stochastic Oscillator
- YMAB 70.47
- SEVN 34.15
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.